These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4982009)

  • 1. [Ethambutol and pulmonary tuberculosis].
    Pilheu JA; Iannello JA; Palermo F
    Torax; 1969 Jun; 18(2):91-6. PubMed ID: 4982009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ethambutol in the chemotherapy of patients with fibrocavernous tuberculosis of the lungs].
    Utkin VV; Poleshchuk AK; Zankisova IG; Mkrtchian SV; Krylova NP; Gridneva SM
    Probl Tuberk; 1971; 49(7):27-32. PubMed ID: 5005808
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ethambutol in phthisiological experimentation and practice].
    Galassi A; Campanini A; Ciaccia A
    G Ital Chemioter; 1966; 13(1):90-108. PubMed ID: 4967907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ethambutol in chemotherapy of patients with fibro-cavitary tuberculosis of the lungs].
    Utkin VV; Poleshchuk AK; Zankisova IG; Mkrtchian SV; Krylova NP
    Probl Tuberk; 1971; 49(7):27-32. PubMed ID: 5004349
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C; Kaufman S; Barcan F; Gheorghiu M; Cristea M; Ulpian C; Iancovici O
    Ftiziologia; 1971; 20(4):373-9. PubMed ID: 5005706
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neutralization of the sputum in newly detected patients with pulmonary tuberculosis treated during the years 1967 to 1970].
    Panajotović H; Marsenić B
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():105-9. PubMed ID: 4216916
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimycobacterial activity of ethambutol in human pulmonary mononuclear phagocytes.
    Liss RH
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():485-6. PubMed ID: 6417642
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethambutol-sensitivity of mycobacteria].
    Lucchesi M; Termine A; Mancini P
    Ann Ist Carlo Forlanini; 1969; 29(1):51-9. PubMed ID: 4996682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M; Czajka-Kropaczek L; Ciechanowska A
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution to the study of the antimycobacterial activity of ethambutel in chronic pulmonary tuberculosis].
    Ramacciotti PG; Lijoi N; Busin M
    G Ital Mal Torace; 1967; 21(4):197-200. PubMed ID: 4970414
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with long-term application of ethambutol in ambulatory and hospitalized patients with chronic destructive tuberculosis of the lungs].
    Rudoi NM; Eisaev BA
    Probl Tuberk; 1973; 51(1):42-6. PubMed ID: 4199376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal function under the effect of ethambutol treatment of patients with destructive pulmonary tuberculosis].
    Klochkova LS; Krasnitskiĭ BI
    Vrach Delo; 1976 Aug; (8):103-6. PubMed ID: 1020265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mycobacterial resistance to ethambutol].
    Battaglia B
    Lotta Tuberc; 1971; 41(3):397-400. PubMed ID: 5003854
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of ethambutol in higher and regular doses in the treatment of patients with chronic destructive forms of pulmonary tuberculosis].
    Bialik IB
    Probl Tuberk; 1988; (6):30-3. PubMed ID: 3145497
    [No Abstract]   [Full Text] [Related]  

  • 19. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE
    Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.